Meet the Team: Eleanor Fallon, MD - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Meet the Team: Eleanor Fallon, MD

Eleanor Fallon, MD, joined Roswell Park Comprehensive Cancer Center to combine her two passions: treating melanoma and non-melanoma skin cancers and research into how immunotherapy can be used to make other therapies more effective.

  • January 16, 2026

Share

Clinical Scorecard: Meet the Team: Eleanor Fallon, MD

At a Glance

CategoryDetail
ConditionMelanoma and non-melanoma skin cancers
Key MechanismsImmunotherapy, tumor immune microenvironment, immune checkpoint blockade, intralesional therapies
Target PopulationPatients with melanoma and non-melanoma skin cancers
Care SettingComprehensive cancer center

Key Highlights

  • Focus on combining treatment and research in melanoma and skin cancers
  • Investigating the tumor immune microenvironment and its modulation
  • Research on gut microbiome's impact on immunotherapy resistance
  • Emphasis on precision therapy and lifestyle modifications
  • Collaboration between surgical oncology and immunology

Guideline-Based Recommendations

Diagnosis

  • Utilize clinical trials to inform treatment decisions
  • Assess tumor immune microenvironment for personalized therapy

Management

  • Incorporate immunotherapy as a primary treatment for melanoma
  • Explore regional and intralesional therapies for advanced disease

Monitoring & Follow-up

  • Monitor patient response to immunotherapy and adjust treatment accordingly
  • Evaluate lifestyle and dietary factors that may influence treatment outcomes

Risks

  • Potential resistance to immunotherapy
  • Variability in patient responses based on immune system health

Patient & Prescribing Data

Patients with advanced melanoma and non-melanoma skin cancers

Combination therapies and lifestyle modifications may enhance treatment efficacy

Clinical Best Practices

  • Adopt a multidisciplinary approach in cancer treatment
  • Stay updated on the latest research in immunotherapy
  • Encourage patient participation in clinical trials

Related Resources & Content

    Original Source(s)

    Meet the Team: Eleanor Fallon, MD

    • January 16, 2026

    Related Content

    Cost-Effectiveness of Electronic Patient-Reported Outcome Measure Interventions in Cancer: Systematic Review and Parameter Extraction for Economic Modeling

    Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer

    The goal of this clinical trial is to learn if Adaptive Radiation Therapy (ART) is safe and effective in treating patients with locally advanced pancreatic cancer.

    • by

    • September 4, 2026

    • 4 min
    CAR T Before Surgery Improves Glioblastoma Control in Mice

    Study finds that tumor resection creates a more immunosuppressive environment and that earlier CAR T cell treatment prolongs survival

    • September 7, 2026

    • 3 min